SRC and pancreatic neoplasm: Collectively, these data indicate that Src inhibition may partially stabilize E-cadherin-based cell-cell junctions and could retard early pancreatic tumor cell dissociation and, subsequently, decrease invasive efficiency by inducing tumor cell clustering.